Researchers at La Trobe University have identified a previously unknown transmission pathway for SARS-CoV-2, revealing that the virus can infiltrate immune cells by hiding within the debris of dying cells. According to lead researcher Kha Phan, this mechanism triggers a severe inflammatory response, offering a potential target for future treatments aimed at preventing complications like long COVID.
How SARS-CoV-2 Hijacks Immune Cell Cleanup
The human body relies on macrophages—specialized immune cells—to clear away cellular debris. New findings from the La Trobe Institute for Molecular Science suggest that SARS-CoV-2 exploits this natural “housekeeping” process. When a cell infected with the virus dies, the virus remains within the cellular fragments. As macrophages engulf this debris, they inadvertently ingest the virus, allowing it to gain a foothold inside the immune system.
Once inside the macrophage, the virus spreads to other immune cells. Kha Phan, a National Health and Medical Research Centre emerging leadership fellow, describes this as a “novel pathway of viral transmission.” Instead of simply being neutralized, the virus turns the macrophage’s own defensive mechanisms against the body, causing the intense inflammation often observed in severe COVID-19 cases.
Macrophages are immune cells that engulf cellular debris during the body’s natural clean-up process.
Implications for COVID-19 Treatment and Long-Term Care
Understanding this pathway could shift how clinicians approach the early stages of a viral infection. By identifying the mechanism that drives extreme inflammation, researchers hope to develop targeted therapies that can dampen this response before it causes permanent lung damage.
“This fundamentally shifts the way we think about viral infections and solves a long-standing puzzle about how COVID-19 infects immune cells and drives severe inflammation,” Phan stated. He suggests that if effective treatments are applied earlier in the infection cycle, the risk of developing lingering health issues, such as long COVID, could be significantly reduced.
Broader Impacts on Pandemic Preparedness
While this research focuses on SARS-CoV-2, its relevance extends to other respiratory illnesses. Similar inflammatory processes could exist in viral diseases like influenza and respiratory syncytial virus (RSV). According to the World Health Organization, seasonal flu alone accounts for up to 650,000 deaths annually, while COVID-19 has been linked to more than seven million global deaths since 2019.
Stuart Turville, an associate professor at UNSW’s Kirby Institute, emphasizes that these findings are critical for future pandemic preparedness. He notes that while the current study utilized an early strain of the virus—which differs from modern variants that are more likely to infect the upper respiratory tract—the underlying biology remains a vital area of study.
“We’ve got to be mindful not to be apathetic about not researching this virus anymore,” Turville said. “There’s going to be a future similar one like this, whether it be coronavirus or another respiratory virus, that’s going to have very similar traits.”
Stay informed about ongoing respiratory health research by checking updates from the World Health Organization or the Kirby Institute, which frequently publishes findings on molecular virology and pandemic response strategies.
Frequently Asked Questions
- How does SARS-CoV-2 enter immune cells?
- The virus hides in the debris of dying cells. When macrophages attempt to clear this debris, they ingest the virus, allowing it to infect the immune cells from the inside.
- Why does this lead to lung damage?
- The virus triggers an inflammatory response within the macrophages. This immune reaction causes damage to the surrounding lung tissue.
- Does this research apply to current COVID-19 variants?
- The study used an early strain of SARS-CoV-2. Experts note that while current variants behave differently, the discovery provides a blueprint for understanding how similar respiratory viruses function at a molecular level.
Have questions about how current research is shaping public health policy? Join the conversation in the comments below or subscribe to our newsletter for the latest updates on medical breakthroughs.
